Where does Mission Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Mission Bio's 2 recorded funding rounds.

Premier Alternatives

Mission Bio

San Francisco, CA · Founded 2011 · Privately Held (backing)

Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution. Mission Bio is based in San Francisco, CA and was founded in 2011. It was valued at $300 million at its later-stage round in May 2022, the last priced event on record. It has raised $212 million across 2 recorded rounds; the latest was a $28.4 million early-stage round in Jun 2018.

PMV mark · valuation

$300.0M

Oct 2026

Priced at

its later-stage round

May 2022

Total raised

$212.1M

Last round

Early Stage VC

Jun 2018

Cap table — not yet on record

Mission Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Mission Bio with a free account

·The complete investor list: 41 names
·Watch Mission Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Mission Bio

Where does Mission Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Mission Bio's 2 recorded funding rounds.